These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6158667)

  • 21. [Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
    Wuttke H; Schlieter D; Krück F
    Klin Wochenschr; 1979 Jan; 57(2):69-74. PubMed ID: 84095
    [No Abstract]   [Full Text] [Related]  

  • 22. Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease.
    MacFarlane IA; Davies D; Longson D; Shalet SM; Beardwell CG
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):557-61. PubMed ID: 6411390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal Graves' Eye Disease.
    Segal KL; Nelson CC
    Ophthalmology; 2017 May; 124(5):673. PubMed ID: 28433126
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
    Takamatsu J
    Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of T3-predominant Graves' disease].
    Lin LX
    Zhonghua Yi Xue Za Zhi; 1988 Feb; 68(2):79-81. PubMed ID: 2457417
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators.
    Prakash R
    Eur J Nucl Med; 1996 Feb; 23(2):118-22. PubMed ID: 8925844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism.
    Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N; Kato R
    Endocrinol Jpn; 1991 Dec; 38(6):683-7. PubMed ID: 1726635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotoxicosis: relations between clinical state and biochemical changes during carbimazole treatment.
    Mortimer CH; Anderson DC; Liendo-Ch P; Fisher R; Chan V; Self M; Besser GM
    Br Med J; 1977 Jan; 1(6054):138-41. PubMed ID: 401664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves' disease presenting as hemiparkinsonism.
    Davies JS; Morrish PK; Scanlon MF
    J Endocrinol Invest; 2001 Mar; 24(3):188-9. PubMed ID: 11314749
    [No Abstract]   [Full Text] [Related]  

  • 30. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
    Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
    Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
    [No Abstract]   [Full Text] [Related]  

  • 31. The regulation of thyrotrophin secretion by exogenous thyroxine and triiodothyronine.
    Yeo PP; Lewis M; Davies TF; Weightman DR; Marshall J; Ratcliffe JG; Evered DC
    Clin Chim Acta; 1979 Dec; 99(3):203-10. PubMed ID: 583260
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy.
    Bliddal H; Kirkegaard C; Siersbaek-Nielsen K; Friis T
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):364-9. PubMed ID: 6170200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocrine opthalmopathy-- new physiopathological viewpoints through the determination of T3, T4 and TSH following TRH stimulation].
    Loos U; Rothenbuchner G; Birk J; Ishihara A; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1974; 80():1340-3. PubMed ID: 4217981
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of antithyroid treatment on the pituitary thyrotropin reserve in patients with Basedow's disease].
    Gianrossi R; Murialdo G; Gallamini A; Rolandi E
    Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2082-7. PubMed ID: 71904
    [No Abstract]   [Full Text] [Related]  

  • 35. TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates.
    Pujol P; Osman A; Grabar S; Daurès JP; Galtier-Dereure F; Boegner C; Baldet L; Raye R; Bringer J; Jaffiol C
    Clin Endocrinol (Oxf); 1998 May; 48(5):635-40. PubMed ID: 9666876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
    Dahlberg PA; Karlsson FA; Lindström B; Wide L
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):555-62. PubMed ID: 6895351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
    Irie M; Enomoto K; Inoue K; Enomoto H; Nukii T
    Horumon To Rinsho; 1974 Feb; 22(2):249-50. PubMed ID: 4136015
    [No Abstract]   [Full Text] [Related]  

  • 38. Graves' disease associated with elevated serum thyroxine-binding globulin concentrations.
    Yabu Y; Amino N; Nakatani K; Ichihara K; Azukizawa M; Miyai K
    J Clin Endocrinol Metab; 1980 Aug; 51(2):325-9. PubMed ID: 6772663
    [No Abstract]   [Full Text] [Related]  

  • 39. Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
    Heshmati HM; Izembart M; Turpin G; Vallée G
    Horm Metab Res; 1991 Mar; 23(3):148. PubMed ID: 1864563
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithyroid drug treatment of von Basedow's disease: results from a multicenter study.
    Benker G; Nolte C; Olbricht T; Reinwein D; Kahaly G; Galvan G; Hackenberg K; Gräf KJ; Schneider HG; Ziegler R
    Exp Clin Endocrinol; 1991 May; 97(2-3):252-6. PubMed ID: 1915641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.